[Experience with complex treatment for childhood amblyopia]

Vestnik Oftalmologii
|March 6, 2008
PubMed

Insights

Mexidole significantly improved vision treatment in children with amblyopia (lazy eye). This drug enhanced pleoptic treatment effectiveness and maintained visual function, showing positive effects on visually evoked potentials.

Area of Science:

  • Ophthalmology
  • Pediatric Neurology
  • Pharmacology

Background:

  • Amblyopia, or lazy eye, affects visual development in children.
  • Effective treatment strategies are crucial for achieving stable visual function.
  • Pleoptic treatment is a common approach for managing amblyopia.

Purpose of the Study:

  • To evaluate the efficacy of mexidole as an adjunct therapy for amblyopia in children.
  • To assess the impact of mexidole on the efficiency and stability of visual function.
  • To investigate the effect of mexidole on visually evoked potentials (VEPs).

Main Methods:

  • A study group of 36 children with amblyopia received standard pleoptic treatment plus mexidole.
  • A control group of 30 children with amblyopia received only pleoptic treatment.
  • Visually evoked potentials were measured to assess visual pathway function.

Main Results:

  • Mexidole enhanced the effectiveness of complex pleoptic treatment in 83% of cases.
  • The addition of mexidole led to sustained visual function improvements.
  • Mexidole demonstrated a positive influence on visually evoked potential values.

Conclusions:

  • Mexidole is an effective therapeutic agent for improving amblyopia treatment outcomes in children.
  • Adjunctive mexidole therapy promotes long-term visual function stability.
  • Mexidole positively modulates neurophysiological responses in the visual system.